BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 20303034)

  • 1. Blood still kills: six strategies to further reduce allogeneic blood transfusion-related mortality.
    Vamvakas EC; Blajchman MA
    Transfus Med Rev; 2010 Apr; 24(2):77-124. PubMed ID: 20303034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention.
    Vamvakas EC; Blajchman MA
    Blood; 2009 Apr; 113(15):3406-17. PubMed ID: 19188662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogen-reduced platelets for the prevention of bleeding.
    Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk-reduction strategies for platelet transfusion in the United States.
    Vamvakas EC
    ScientificWorldJournal; 2011 Mar; 11():624-40. PubMed ID: 21403979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
    Hitzler WE
    Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relative safety of pooled whole-blood-derived platelets prepared by the buffy-coat method versus single-donor (apheresis) platelets.
    Vamvakas EC
    Clin Lab; 2010; 56(7-8):263-79. PubMed ID: 20857891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare antibody-associated hemolytic transfusion reaction and transfusion-related acute lung injury: a case report.
    Beck TN; Young NG; Erickson ML; Prats I
    BMC Surg; 2017 Apr; 17(1):48. PubMed ID: 28441942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical transfusion practice update: haemovigilance, complications, patient blood management and national standards.
    Engelbrecht S; Wood EM; Cole-Sinclair MF
    Med J Aust; 2013 Sep; 199(6):397-401. PubMed ID: 24033212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicted effect of selectively testing female donors for HLA antibodies to mitigate transfusion-related acute lung injury risk from apheresis platelets.
    Eder AF; Dy BA; O'Neill EM
    Transfusion; 2016 Jun; 56(6 Pt 2):1608-15. PubMed ID: 26830063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protecting the blood supply from emerging pathogens: the role of pathogen inactivation.
    Blajchman MA
    Transfus Clin Biol; 2009 May; 16(2):70-4. PubMed ID: 19427252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supplemental findings of the 2019 National Blood Collection and Utilization Survey.
    Mowla SJ; Sapiano MRP; Jones JM; Berger JJ; Basavaraju SV
    Transfusion; 2021 Sep; 61 Suppl 2(Suppl 2):S11-S35. PubMed ID: 34337759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-risk transfusion-related acute lung injury donor strategies and the impact on the onset of transfusion-related acute lung injury: a meta-analysis.
    Müller MC; van Stein D; Binnekade JM; van Rhenen DJ; Vlaar AP
    Transfusion; 2015 Jan; 55(1):164-75. PubMed ID: 25135630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood-Borne Pathogens: A Canadian Blood Services Centre for Innovation Symposium.
    Walsh GM; Shih AW; Solh Z; Golder M; Schubert P; Fearon M; Sheffield WP
    Transfus Med Rev; 2016 Apr; 30(2):53-68. PubMed ID: 26962008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion-Transmitted Infections Reported to the National Healthcare Safety Network Hemovigilance Module.
    Haass KA; Sapiano MRP; Savinkina A; Kuehnert MJ; Basavaraju SV
    Transfus Med Rev; 2019 Apr; 33(2):84-91. PubMed ID: 30930009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative strategies in assuring blood safety: An overview.
    Epstein JS
    Biologicals; 2010 Jan; 38(1):31-5. PubMed ID: 20110174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative safety of pooled whole blood-derived versus single-donor (apheresis) platelets in the United States: a systematic review of disparate risks.
    Vamvakas EC
    Transfusion; 2009 Dec; 49(12):2743-58. PubMed ID: 19682339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative risk of reducing the lifetime blood donation deferral for men who have had sex with men versus currently tolerated transfusion risks.
    Vamvakas EC
    Transfus Med Rev; 2011 Jan; 25(1):47-60. PubMed ID: 21134626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and associated risk factors of transfusion transmissible infections among blood donors at Regional Blood Transfusion Center Nakuru and Tenwek Mission Hospital, Kenya.
    Bartonjo G; Oundo J; Ng'ang'a Z
    Pan Afr Med J; 2019; 34():31. PubMed ID: 31762899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological complications of blood transfusions.
    Brand A
    Presse Med; 2016; 45(7-8 Pt 2):e313-24. PubMed ID: 27499223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Update on infectious risks associated with blood products].
    Traineau R; Elghouzzi MH; Bierling P
    Rev Prat; 2009 Jan; 59(1):86-9. PubMed ID: 19253889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.